Cite
MLA Citation
Meletios A Dimopoulos et al.. “Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial.” Lancet, vol. 9, no. 6, 2022, pp. e403–e414. http://access.bl.uk/ark:/81055/vdc_100155166809.0x000017